Protocol for generating NGN2 iPSC lines and large-scale human neuron production.

Area of Science:

• Stem cell biology
• Neuroscience
• Biotechnology

Background:

• Large-scale production of induced pluripotent stem cell (iPSC)-derived neurons is essential for disease modeling and drug discovery.
• Existing methods may lack scalability or efficiency for widespread application.

Purpose of the Study:

• To develop and validate a robust workflow for engineering iPSCs to produce large quantities of neurons.
• To optimize the process for high-efficiency generation of neuronal cells for research applications.

Main Methods:

• Engineering of a doxycycline-inducible NGN2 cassette into the AAVS1 locus of iPSCs.
• Utilizing ribonucleoprotein electroporation and a donor plasmid for genetic modification.
• Employing homology-directed repair enhancement, antibiotic selection, and fluorescence for clone validation.

Main Results:

• Successful differentiation of validated iPSC clones into neurons within 5 days.
• Achieved production at a scale of billions of neurons.
• Demonstrated cryopreservation and long-term maintenance capabilities for the derived neurons.

Conclusions:

• The described workflow enables efficient, large-scale production of iPSC-derived neurons.
• This method significantly supports applications in disease modeling and pharmaceutical drug discovery.
• The generated neurons are stable and suitable for various downstream experimental procedures.